## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract; no access to full text, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The authors report computational and experimental analyses of phosphorylation in HTLV-1 p30 protein, examining how phosphorylation at 10 predicted sites versus 3 experimentally identified sites affects the intrinsically disordered nature, conformational dynamics, and interaction with the viral regulatory protein Rex. They conclude that higher phosphorylation levels increase stability and compactness, and that Rex binding within disordered regions modulates p30 conformational ensemble, with limited phosphorylation plus Rex interaction contributing to structural stability required for p30 multifunctionality.
- **Visible evidence base** Abstract text only; no methodological details, numerical results, figures, or statistical analyses provided
- **Missing materials affecting confidence** Full manuscript, methods section, all figures and tables, experimental phosphorylation identification data, MD simulation parameters and trajectories, interaction assay details, statistical analyses, and any validation experiments

## Reviewer
- **Overall assessment** The abstract presents a potentially interesting study on post-translational modification effects on an intrinsically disordered viral protein, with relevance to HTLV-1 biology. However, the evidence base available for review is limited to the abstract, which lacks sufficient methodological detail, quantitative results, and validation to assess the robustness of the claims. The central conclusions regarding phosphorylation-dependent stability and Rex-mediated modulation are plausible but not adequately supported by the information provided.
- **Who would be interested in the results, and why** Researchers studying HTLV-1 pathogenesis and viral persistence mechanisms, particularly those focused on accessory protein functions. Also relevant to investigators interested in intrinsically disordered proteins, phosphorylation-dependent conformational regulation, and computational approaches to studying IDP dynamics. The findings could inform understanding of how post-translational modifications tune IDP function in viral contexts.
- **Major strengths** The study addresses a relevant and under-explored question about how phosphorylation modulates the disordered nature of a viral accessory protein. The comparison between predicted and experimentally identified phosphorylation sites is a useful approach. The inclusion of protein-protein interaction analysis with Rex adds biological context beyond purely biophysical characterization.
- **Major Concerns**  
  - R1-M1  
  - R1-M2  
  - R1-M3  
  - R1-M4
- **Minor Comments**  
  - R1-m1  
  - R1-m2  
  - R1-m3  
  - R1-m4
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3
- **Assessment against Nature-style criteria**  
  **Originality** The question of how phosphorylation affects IDP behavior in a viral accessory protein is not entirely novel, but the specific focus on HTLV-1 p30 and the comparison between predicted and experimental sites offers some originality. However, the abstract does not clearly articulate what new conceptual insight beyond existing IDP phosphorylation studies is provided.  
  **Scientific importance** The topic has relevance to HTLV-1 biology and IDP research, but the abstract does not establish broader significance beyond the specific viral system. The potential implications for understanding viral latency and replication are mentioned but not developed.  
  **Interdisciplinary readership** The work sits at the intersection of virology, structural biology, and computational biophysics, which could attract readers from multiple fields. However, the abstract does not frame the findings in a way that would engage nonspecialists from these different communities.  
  **Technical soundness** Cannot be adequately assessed from the abstract alone. The lack of methodological detail, simulation parameters, experimental validation procedures, and statistical analyses prevents evaluation of technical rigor.  
  **Readability for nonspecialists** The abstract is generally readable but uses field-specific terminology (e.g., "intrinsically disordered protein," "conformational ensemble") without sufficient context. The logical flow from phosphorylation analysis to Rex interaction to functional conclusions is somewhat abrupt.
- **Recommendation posture** Currently not established from the provided evidence. The abstract presents interesting hypotheses and preliminary findings, but the limited information available does not allow verification of the core claims. A supportive posture would require access to the full manuscript with detailed methods, results, and validation.

### Major Concerns

- **Concern ID** R1-M1  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Technical soundness  
- **Claim pointer** The abstract claims that "p30 with phosphorylation at 10 predicted sites (p30-10site(-P)), exhibited more stable behavior and higher compactness compared to p30 with phosphorylation at 3 experimentally identified sites (p30-3site(-P)) and apo-protein."  
- **Evidence pointer** Abstract, results description; location not provided  
- **Concern** The abstract provides no quantitative data supporting the stability and compactness comparison. No metrics such as radius of gyration, root-mean-square deviation, root-mean-square fluctuation, solvent-accessible surface area, or free energy values are reported. The criteria for "stable behavior" and "higher compactness" are undefined.  
- **Why it matters** Without quantitative measures and statistical significance testing, the central comparative claim cannot be evaluated. The conclusion that 10-site phosphorylation confers greater stability than 3-site phosphorylation or apo-p30 requires robust numerical evidence and error analysis.  
- **Resolution test** Provide specific MD-derived metrics with standard deviations or confidence intervals for each system, along with statistical tests demonstrating significant differences between conditions. Include convergence analysis and replicate simulations.

- **Concern ID** R1-M2  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Technical soundness  
- **Claim pointer** The abstract states that "the interaction between p30 and Rex modulates the balance between viral replication and latency" and that "the stability of p30 in the p30-Rex complex is also influenced by its binding partners (Rex protein), as the binding sites are located within the ID regions of p30."  
- **Evidence pointer** Abstract, interaction analysis description; location not provided  
- **Concern** The abstract does not describe how the p30-Rex interaction was modeled or experimentally validated. No details on docking protocols, simulation timescales, binding free energy calculations, or experimental binding assays are provided. The claim that binding sites are located within ID regions is stated without supporting structural or computational evidence.  
- **Why it matters** The functional conclusion linking Rex binding to p30 stability and viral latency depends entirely on the validity of the interaction analysis. Without methodological transparency and validation, this claim remains unsupported.  
- **Resolution test** Describe the computational or experimental approach used to characterize the p30-Rex interaction, provide binding affinity data or interaction energy profiles, and show residue-level mapping of binding sites within disordered regions with appropriate confidence measures.

- **Concern ID** R1-M3  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Reproducibility  
- **Claim pointer** The abstract implies that phosphorylation sites were identified experimentally ("3 experimentally identified sites") and predicted computationally ("10 predicted sites").  
- **Evidence pointer** Abstract, methods description; location not provided  
- **Concern** No information is provided about how the experimental phosphorylation sites were identified (e.g., mass spectrometry, mutagenesis, phospho-specific antibodies) or which prediction algorithms were used for the 10 sites. The criteria for selecting these specific sites and the confidence levels of predictions are absent.  
- **Why it matters** Reproducibility requires clear specification of experimental and computational methods. Without this information, readers cannot assess the reliability of the phosphorylation site assignments, which are foundational to the entire study.  
- **Resolution test** Provide detailed methods for experimental phosphorylation identification including sample preparation, instrumentation, and data analysis criteria. Specify prediction tools, versions, and thresholds used for the 10-site prediction.

- **Concern ID** R1-M4  
- **Severity** Major  
- **Blocking** No  
- **Axis** Scientific importance  
- **Claim pointer** The abstract concludes that "limited phosphorylation together with Rex interaction may contribute to the structural stability of p30 which is required for its multifunctional role in HTLV-1 infection."  
- **Evidence pointer** Abstract, conclusion; location not provided  
- **Concern** The functional significance of the observed stability differences is inferred rather than demonstrated. The abstract does not connect the biophysical findings to any functional assay of p30 activity, viral replication, or latency. The phrase "may contribute" appropriately hedges, but the relevance to HTLV-1 infection remains speculative.  
- **Why it matters** For a study to have broad impact, the biophysical observations should be linked to biological function. Without functional validation, the significance of the phosphorylation-dependent stability changes for viral pathogenesis is unclear.  
- **Resolution test** Include functional experiments such as reporter assays for p30 transcriptional activity, viral replication assays with phosphorylation site mutants, or cellular localization studies that connect the observed conformational changes to biological outcomes.

### Minor Comments

- **Concern ID** R1-m1  
- **Severity** Minor  
- **Axis** Clarity  
- **Affected element** Terminology  
- **Evidence pointer** Abstract, first paragraph  
- **Issue** The term "intrinsically disordered protein (IDP) nature" is used without defining what specific disorder predictions or experimental evidence support this classification for p30.  
- **Required correction** Briefly state the basis for classifying p30 as an IDP, such as prediction scores from tools like IUPred or PONDR, or experimental evidence from circular dichroism or NMR.

- **Concern ID** R1-m2  
- **Severity** Minor  
- **Axis** Completeness  
- **Affected element** Methods description  
- **Evidence pointer** Abstract, methods description  
- **Issue** The abstract mentions "MD studies" but does not specify the force field, water model, simulation length, temperature, or number of replicates.  
- **Required correction** Include key simulation parameters in the abstract or indicate that full details are in the methods section.

- **Concern ID** R1-m3  
- **Severity** Minor  
- **Axis** Interpretation  
- **Affected element** Secondary structure analysis  
- **Evidence pointer** Abstract, results description  
- **Issue** The statement that "a significant percentage of loops were observed in their secondary structure" for p30 and Rex is vague. The biological meaning of loop content in IDPs is not explained.  
- **Required correction** Provide quantitative loop percentages and explain how this observation relates to disorder and function.

- **Concern ID** R1-m4  
- **Severity** Minor  
- **Axis** Presentation  
- **Affected element** Figure references  
- **Evidence pointer** Abstract, results description  
- **Issue** No figure or table references are provided in the abstract, making it difficult to locate supporting data.  
- **Required correction** Add references to key figures or tables that display the stability, compactness, and interaction results.

## Risk / unsupported claims
- The comparative stability and compactness claim for p30-10site(-P) versus p30-3site(-P) and apo-p30 is unsupported by quantitative data in the abstract.
- The claim that Rex binding sites are located within ID regions of p30 is unsupported by structural or interaction data in the abstract.
- The conclusion that limited phosphorylation plus Rex interaction contributes to p30 structural stability required for multifunctional roles in HTLV-1 infection is speculative and not connected to functional evidence.
- The classification of p30 as an IDP is stated without supporting prediction or experimental evidence.
- The functional relevance of the observed conformational changes to viral replication and latency is asserted without experimental validation.